Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 13.551.571.551.401.55

What is the latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS is 13.55 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202513.55
Mar20241.57
Mar20231.55
Mar20221.40
Mar20211.55

How is EV/Core EBITDA of EMCURE PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 13.55
763.06
Mar2024 1.57
1.29
Mar2023 1.55
10.71
Mar2022 1.4
-9.68
Mar2021 1.55 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹27,218.0 Cr -7.8% 0.2% 10.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹381,326.0 Cr -0.2% -6.3% -8.8% Stock Analytics
DIVIS LABORATORIES ₹160,299.0 Cr 3.3% -3.4% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,821.0 Cr -0.7% 3.8% 26.3% Stock Analytics
CIPLA ₹106,655.0 Cr -3% -11.8% -8.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,861.0 Cr 6% -3.5% -4.3% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-7.8%

0.2%

10.1%

SENSEX

0.8%

-2.9%

8.1%


You may also like the below Video Courses